Mastectomy, Segmental

• 

  Subject Areas on Research

  • A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor Margins. 
  • A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers. 
  • A national snapshot of satisfaction with breast cancer procedures. 
  • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). 
  • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). 
  • Accelerated partial breast irradiation: caution and concern from an ASTRO task force. 
  • Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. 
  • Additional Lumpectomy and Irradiation for In-Breast Recurrence of Cancer-When Less Is More. 
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. 
  • Advancing optical imaging for breast margin assessment: an analysis of excisional time, cautery, and patent blue dye on underlying sources of contrast. 
  • American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. 
  • Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. 
  • Applying the neoadjuvant paradigm to ductal carcinoma in situ. 
  • Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients. 
  • Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer. 
  • Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. 
  • Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma. 
  • Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy. 
  • Breast conservation rates-barriers between tertiary care and community practice. 
  • Breast conservation surgery using nipple-areolar resection for central breast cancers. 
  • Breast conservation: is the survival better for mastectomy? 
  • Breast lidocaine priming for improved mastectomy survival. 
  • Breast papillomas in the era of percutaneous needle biopsy. 
  • Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program. 
  • Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. 
  • Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ. 
  • Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. 
  • Cost implications of the SSO-ASTRO consensus guideline on margins for breast-conserving surgery with whole breast irradiation in stage I and II invasive breast cancer. 
  • Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome. 
  • Does Breast Cancer Subtype Impact Margin Status in Patients Undergoing Partial Mastectomy? 
  • Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy? 
  • Does Localization Technique Matter for Non-palpable Breast Cancers? 
  • Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? 
  • Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women. 
  • Ductal carcinoma in situ: a review of recent advances. 
  • Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center. 
  • Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast. 
  • Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. 
  • Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. 
  • Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery. 
  • Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. 
  • Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. 
  • Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. 
  • Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer. 
  • How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS. 
  • Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ. 
  • Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study. 
  • Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation. 
  • Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer. 
  • Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. 
  • Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of Appalachia. 
  • Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia. 
  • Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? 
  • Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? 
  • Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer. 
  • Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). 
  • MRI predictors of tumor-positive margins after breast-conserving surgery. 
  • Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast. 
  • Management of ductal carcinoma in situ. 
  • Miniature spectral imaging device for wide-field quantitative functional imaging of the morphological landscape of breast tumor margins. 
  • Mobile Health Application for Patients Undergoing Breast Cancer Surgery: Feasibility Study. 
  • Modeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data. 
  • Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set. 
  • Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. 
  • Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis. 
  • Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care. 
  • Oncoplastic surgery: fashion or necessity? 
  • Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 
  • Paravertebral somatic nerve blocks for breast surgery in a patient with hypertrophic obstructive cardiomyopathy. 
  • Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors. 
  • Performance of preoperative breast MRI based on breast cancer molecular subtype. 
  • Persistent Breast Pain Among Women With Histories of Breast-conserving Surgery for Breast Cancer Compared With Women Without Histories of Breast Surgery or Cancer. 
  • Predicting a local recurrence after breast-conserving therapy by gene expression profiling. 
  • Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers. 
  • Primary systemic therapy in HER2-amplified breast cancer: a clinical review. 
  • Rapid noninvasive optical imaging of tissue composition in breast tumor margins. 
  • Recurrence risk and margin status in granular cell tumors of the breast: a clinicopathologic study of 13 patients. 
  • Regional Nodal Irradiation in the Modern Era of Breast Cancer Management. 
  • Reoperation for Margins After Breast Conservation Surgery: What's Old Is New Again. 
  • Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial. 
  • Risk factors for surgical site infections after breast surgery: a systematic review and meta-analysis. 
  • Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. 
  • Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins. 
  • Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 
  • Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 
  • Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 
  • Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. 
  • Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ. 
  • Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. 
  • Surgery for Men with Breast Cancer: Do the Same Data Still Apply? 
  • Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. 
  • Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. 
  • Systemic therapy for older women with breast cancer. 
  • The "Yin and Yang" of Platelet-rich Plasma in Breast Reconstruction After Mastectomy or Lumpectomy for Breast Cancer. 
  • The choice for breast cancer surgery: can women accurately predict postoperative quality of life and disease-related stigma? 
  • The effect of treatment on patient-reported distress after breast cancer diagnosis. 
  • The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy. 
  • The role of tumor phenotype in the surgical treatment of early-stage breast cancer. 
  • The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343. 
  • Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer. 
  • Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study. 
  • Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. 
  • Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality. 
  • Volume of resection in patients treated with breast conservation for ductal carcinoma in situ. 
  • Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines? 
  • What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS? 
  • What's new in neoadjuvant therapy for breast cancer? 
• 

  Keywords of People

  • Nielsen, Karen Cristina, Associate Professor of Anesthesiology, Anesthesiology, Ambulatory